BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Anika Reports Third Quarter 2017 Financial Results

  Anika Therapeutics, Inc. reported financial results for the third quarter ended September 30, 2017, along with business progress in the period.

  October 25, 2017

   · 

  11 min read
• Lone Star Bio

  CoorsTek Medical Announces the First Human Implantation of a New, State-of-the-Art Sacroiliac Fusion System

  CoorsTek Medical announced the first human implantation of a new generation of MIS Sacroiliac fusion implants.

  October 25, 2017

   · 

  2 min read
• Business

  PDL BioPharma to Announce Third Quarter 2017 Financial Results on November 2, 2017

  PDL BioPharma today announced that the Company will release its third quarter financial results for the period ended September 30, 2017, on Thursday, November 2, 2017, after market close.

  October 25, 2017

   · 

  2 min read
• Policy

  MabSpace Biosciences Submits Investigational New Drug Application for Its Second Generation PD-L1 Antibody With pH-Dependent Antigen Binding Property

  MabSpace Biosciences announced it has filed an IND application to CFDA on September 12th, 2017 for MSB2311, a second-generation PD-L1 antibody with pH-dependent antigen binding property.

  October 25, 2017

   · 

  2 min read
• Business

  Supernus to Host Third Quarter 2017 Earnings Conference Call

  Management will host a conference call to present the third quarter 2017 business results on Tuesday, November 7, 2017 at 9:00 AM ET.

  October 25, 2017

   · 

  1 min read
• Business

  Myriad to Announce Fiscal First-Quarter 2018 Financial Results on November 7, 2017

  The CEO and CFO will provide an overview of Myriad’s financial performance for the fiscal first-quarter and provide a business update.

  October 25, 2017

   · 

  2 min read
• Pharm Country

  Provista Diagnostics’ New Study: Videssa Breast Blood Test Can Effectively Rule Out Breast Cancer, Regardless of Breast Density

  A new study published in PLOS ONE demonstrates that Videssa Breast, a multi-protein biomarker blood test for breast cancer by Provista Diagnostics, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

  October 25, 2017

   · 

  5 min read
• Nexeon Begins Clinical Study With Newly Developed Non-Invasive Vagus Nerve Stimulator

  Nexeon announced its completion of an initial series of clinical studies evaluating the utilization of transcutaneous auricular vagus nerve stimulation (aVNS) for the relief of paroxysmal atrial fibrillation.

  October 25, 2017

   · 

  2 min read
• Relievant Medsystems Announces First Patient Enrollment in the INTRACEPT Clinical Study

  Steven R. Garfin, M.D. is named the principal investigator of the study.

  October 25, 2017

   · 

  5 min read
• Business

  Idera Pharmaceuticals Provides Corporate Governance Update

  Youssef El Zein, Managing Partner of Pillar Invest Corporation has elected to step down from the company’s Board of Directors, effective immediately.

  October 25, 2017

   · 

  4 min read